DGC · Class II · 21 CFR 866.5510

FDA Product Code DGC: Ige, Antigen, Antiserum, Control

Leading manufacturers include Kenota, Inc., Biokit, S.A. and Beckman Coulter, Inc..

114
Total
114
Cleared
65d
Avg days
1977
Since
Stable submission activity - 1 submissions in the last 2 years
Review times increasing: avg 403d recently vs 62d historically

FDA 510(k) Cleared Ige, Antigen, Antiserum, Control Devices (Product Code DGC)

114 devices
1–24 of 114

About Product Code DGC - Regulatory Context

510(k) Submission Activity

114 total 510(k) submissions under product code DGC since 1977, with 114 receiving FDA clearance (average review time: 65 days).

Submission volume has remained relatively stable over the observed period, with 1 submissions in the last 24 months.

FDA Review Time

Recent submissions under DGC have taken an average of 403 days to reach a decision - up from 62 days historically. Manufacturers should account for longer review timelines in current project planning.

DGC devices are reviewed by the Immunology panel. Browse all Immunology devices →